title: High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia.
abstract: (C-X-C motif) ligand 9 and (C-X-C motif) ligand 11 (CXCL9 and CXCL11), are potent chemoattractants for activated T cells, and play an important role in T helper 1 (Th)1 cell recruitment in chronic hepatitis C. No study has evaluated CXCL9, together with CXCL11, circulating levels in patients with mixed cryoglobulinemia and hepatitis C (MC+HCV-p). The aim of the present study therefore was to measure serum CXCL9, and CXCL11 levels, in MC+HCV-p, and to relate the findings to the clinical phenotype. Serum CXCL9 and CXCL11 were measured in 71 MC+HCV-p and in matched controls. MC+HCV-p showed significantly higher mean CXCL9 and CXCL11 levels than controls (P less than 0.001, for both), in particular, in 32 patients with active vasculitis (P less than 0.001). By defining high CXCL9 or CXCL11 level as a value of at least 2 SD above the mean value of the control group ( greater than 100 pg/mL): 89 percent MC+HCV-p and 5 percent controls had high CXCL9 (P less than 0.0001, chi-square); 90 percent MC+HCV-p and 6 percent controls had high CXCL11 (P less than 0.0001, chi-square). In a multiple linear regression model of CXCL9 vs age, ALT, CXCL11, only CXCL11 was significantly (r = 0.452, P less than 0.0001) and independently related to CXCL9. Our study demonstrates in MC+HCV-p vs controls: (i) high serum CXCL9, and CXCL11, significantly associated with the presence of active vasculitis; (ii) a strong relationship between circulating CXCL9 and CXCL11. Future studies on a larger cohort of patients are needed to evaluate the relevance of serum CXCL9 and CXCL11 determination as clinico-prognostic marker of MC+HCV.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. alessandro.antonelli@med.unipi.it
authors.forename: A
authors.initials: A
authors.lastname: Antonelli
authors.forename: P
authors.initials: P
authors.lastname: Fallahi
authors.forename: S M
authors.initials: SM
authors.lastname: Ferrari
authors.forename: S
authors.initials: S
authors.lastname: Frascerra
authors.forename: C
authors.initials: C
authors.lastname: Mancusi
authors.forename: M
authors.initials: M
authors.lastname: Colaci
authors.forename: A
authors.initials: A
authors.lastname: Manfredi
authors.forename: D
authors.initials: D
authors.lastname: Sansonno
authors.forename: A L
authors.initials: AL
authors.lastname: Zignego
authors.forename: C
authors.initials: C
authors.lastname: Ferri
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D054371:Chemokine CXCL11 / Q000097:blood*; D054370:Chemokine CXCL9 / Q000097:blood*; D003449:Cryoglobulinemia / Q000097:blood*; D005260:Female; D006526:Hepatitis C / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D054371:Chemokine CXCL11; D054370:Chemokine CXCL9